Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd. (WVE)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
4. 97
+0.07
+1.4286%
After Hours
$
5. 12
+0.15 +3.0181%
965.54M Market Cap
- P/E Ratio
- Div Yield
3M Volume
-0.62 Eps
$ 4.9
Previous Close
Analysts:
Add Transaction
Day Range
4.8 4.98
Year Range
4.8 21.73
Want to track WVE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Wave Life Sciences Ltd. (WVE) Statistics

Valuation metrics

Market Cap 965.54M
Enterprise value 668.7M
Trailing P/E (ttm) -4.62
Forward P/E -5.78
PEG ratio 0.08
Price/Sales (ttm) 15.19
Price/Book (mrq) 2.25
Enterprise Value/Revenue 10.23
Enterprise Value/EBITDA -3.39

Overview

Shares outstanding 192.34M
Float 90.11M
Shares short 16.72M
% Held by insiders 0.16%
% Held by institutions 0.82%
Average volume (10 days) 2.82M
Average volume (90 days) 3.31M

Price summary

52-Week low 4.8
52-Week high 21.73
Beta -1.32
50-Day moving average 5.42
200-Day moving average 8.76

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin -3.1%
Operating margin -3.33%

Operational effectiveness

Return on assets -0.36%
Return on equity -0.5%

Income Statement

Revenue (ttm) 71.8M
Revenue per share (ttm) 0.32
Quarterly revenue growth (yoy) 3.17%
Gross profit (ttm) -117.8M
EBITDA -193.47M
Net income to common (ttm) -183.59M
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 544.59M
Total cash per share (mrq) 2.43
Total debt (mrq) 15.71M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 9.99%
Book value per share (mrq) 2.24

Cash Flow

Cash flow statement -184.01M
Levered free cash flow (LFCF) -125.72M